Arabic Arabic English English French French German German
dark

Turn Therapeutics Announces Human Trial Data for COVID-19 Early Intervention Candidate

Turn Therapeutics, a biotechnology company specializing in advanced wound care and infection control, today announced the results of its Phase 2B, placebo controlled trial of Hexagen Antimicrobial Ointment in treating mild to moderate infected COVID-19 patients. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

What You Should Do After You Have Suffered A Personal Injury: 6 Critical Steps

Next Post

NRx Pharmaceuticals to Work with Cardinal Health to Ensure Efficient Distribution of Potential Therapies

Related Posts
Total
0
Share